EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance.

Uribe, Mary Luz; Marrocco, Ilaria; Yarden, Yosef

Uribe, Mary Luz; Marrocco, Ilaria; Yarden, Yosef.

Afiliação

Uribe ML; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel.
Marrocco I; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel.
Yarden Y; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel.

Cancers (Basel) ; 13(11)2021 Jun 01.

Article em En | MEDLINE | ID: mdl-34206026

Palavras-chave

anti-cancer drug; drug resistance; growth factor; signal transduction; signaling pathway; transcription network; tyrosine kinase

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article